The Bella Moss Foundation (BMF) is to launch the Human to Animal MRSA Advice Service at the offices of the British Veterinary Association on Friday 22nd October.

The charity says this new online service has been created to provide information and advice on resistant bacteria and their effects on animal health to veterinary professionals, pet owners and carers. 

BMF clinical advisor David Lloyd, professor of veterinary dermatology at the Royal Veterinary College, said: "There has been a worrying increase in the numbers of pets reported with MRSA Infections. The causes for this seem to be complex, and research to understand this emerging infection in animals and people is continuing. The Bella Moss Foundation has been very helpful explaining to pet owners the complexity of these issues, and the new Animal MRSA Advice Service will be an educational tool for lay people and veterinarians to learn more about resistant bacterial infections in animals." 

For pet owners and carers the Animal MRSA Advice Service will provide education on bacteria, the risk factors for transmission between humans and animals, keeping pets healthy, finding a vet, and the importance of hand hygiene in protecting pets and people from unwanted infection.

For veterinary professionals and practice staff the service will also provide academic reports and international research, as well as information on CPD seminars.

If you would like to attend the launch of this new service, please contact info@thebellamossfoundation.com, or call Jill Moss on 07581 736774. 

RCVS Knowledge is calling for all veterinary teams performing neutering in dogs, cats, and rabbits to submit their data to the National Audit for Small Animal Neutering (NASAN) on the vetAUDIT website before the 15th of October.

The NASAN is an audit for practices to share their data anonymously, to establish UK benchmarks in post-operative complications rates for small animal neutering.

Each year, RCVS Knowledge releases the national routine neutering benchmark to enable veterinary teams to compare their figures against the national average and use this data as part of a benchmarking exercise towards continuous improvements for neutering outcomes.

In 2020, 72% of neuters were complication-free, 13% lost to follow, and 15% of animals suffered an abnormality related to the operation, mostly requiring medical treatment.

Chris Gush, Executive Director of RCVS Knowledge, said, “Data submitted to the NASAN last year, and so far this year, has been lower than expected – likely due to the strain put on the professions by the pandemic.

"We believe many practices have neutering data that they have not been able to submit yet. We would be grateful for any unsubmitted neutering data for 2020 and 2021 to be sent to the NASAN, when practices are able, so that it can contribute to the national picture and allow us to gain the most accurate representation of the benchmarks for neutering in the UK.”

RCVS Knowledge is asking that practices submit their data for 2020 and 2021 by the 15th of October.

Anonymised data may already be available via the practice’s PMS and can be added to RCVS Knowledge’s spreadsheet. Practices can use the results to carry out their own audits and produce internal benchmarks, guidelines and checklists to help monitor their progress and help reduce complication rates by using RCVS Knowledge’s free Quality Improvement resources. The yearly benchmarks are reported in November each year.

You can submit your data from 2020 and 2021 on the vetAUDIT website: https://vetaudit.rcvsk.org/nasan

RCVS Knowledge has created a ‘How to guide’ for using the NASAN, which can be watched on YouTube: https://youtu.be/otoyYK3heCQ

FMD
Most of you will be aware that IP8 was declared yesterday. This is a farm in the POZ that was slaughtered on suspicion after detection during surveillance visits. This has lead to further slight changes in the boundaries of the PZ and SZ. These were early lesions and initial laboratory results confirm this.

The epidemiology of the spread of FMD in the area north of Egham suggests that cattle on 4 premises in the vicinity of IP8 have been exposed to infection either via possible aerosol or fomite spread and are likely to develop disease. These premises will be culled as dangerous contacts.

BLUETONGUE
The various zones for controlling Bluetongue have now been defined. These are difficult to describe because they use roads etc. as boundaries but detailed maps and description of the boundaries are available at:

http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/pdf/declaration-bt-pzcz290907.pdf

When farms straddle a road that is a boundary the whole of the farm is classed as being in the zone. It may be possible to put parts of a holding that is outside the zone as a separate unit with consultation with local Animal Health office.

The movement restrictions between the various FMD and BT zones are available at

http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/movements/index.htm

Defra are worried that farmers are not reporting cases of BT because they feel there is nothing that can be done so why bother. It is still a notifiable disease and there is a need to monitor spread for various trade implications. There are, of course, likely to be welfare considerations with clinically affected cases. These will need to be addressed with veterinary consultation and may involve symptomatic treatment or euthanasia.

The prevalence of the disease in infected herds/flocks is still low with 1:53 and 1:190 being affected on surveillance.

Pfizer, manufacturer of the wormer Strongid™-P has launched a new promotional campaign. Love your horse is based on simple, straightforward and unbiased educational messages to help ensure the optimum health and wellbeing of horses and ponies in the UK.

Pfizer's veterinary adviser Ben Gaskell said: “Simplistically, the three key tools for the horse owner to understand are diagnostics, worming and pasture management. If these tools are used in combination with specialist advice, then the horse owner will be able to provide a sustainable, reliable and cost-effective worm control strategy for their horse.”

At the core of the campaign is a new range of four highly informative and uncomplicated leaflets directed at every type of horse owner: Do you need to worm; Choosing and using the right wormer; Managing your pasture and Worming and Your new horse.

“Each leaflet has been designed to work as a stand-alone piece or can be presented as a smart, matching series of four,” said Helen Shirley, brand manager for Strongid™-P. “The leaflets can be displayed in-store in a distinctive counter-top leaflet dispenser and are supported by eye-catching point of sale materials including posters and balloons." The new campaign packs will be rolled out to all stockists from early June, supported by a dramatic new Love your horse advertisement in national equestrian trade and consumer titles.

The campaign will build up momentum over the summer months and into autumn’s double dosing time with a series of authoritative, no-nonsense features and news stories from Strongid™-P’s veterinary advisor Ben Gaskell.

For further information please email: Strongid-P@pfizer.com

A new paper by D J Bartram and D S Baldwin, published in this week's Veterinary Record, has found that veterinary surgeons are four times as likely as the general public, and around twice as likely as other healthcare professionals, to die by suicide as opposed to other causes.

Professor Bill Reilly, President of the British Veterinary Association, said: "David Bartram's research in this difficult area is to be applauded. The more we can understand about the reasons behind the high suicide rate amongst veterinary surgeons, the more the BVA and other bodies can do to support vets in crisis.

"As part of the Vetlife Steering Group, the BVA supports fantastic initiatives such as the 24-hour Vet Helpline for vets, vet nurses and veterinary students, and the Veterinary Benevolent Fund.

"The BVA's Member Services Group (MSG) also spends a lot of time looking at practical initiatives to improve individual vets' day-to day lives. The recent introduction of the mediation and representation services to help resolve issues between veterinary employees and veterinary employers is a good example of the positive ways in which the BVA can support its members in difficult situations.

"The MSG also recently produced a helpline sticker for all veterinary practices to display on the medicines cabinet and other prominent places to act as a constant reminder that help is available.

"Ours is a small profession and many vets will know a friend or colleague who has taken their own life. It is essential that this issue is kept in the open so that those who are struggling know where to turn for help."

Fifty young people from low and middle income backgrounds will have the opportunity to learn what it takes to become a vet and prepare to apply to a veterinary school, at a summer school run by the Sutton Trust and the Royal Veterinary College.

The RVC joins nine other UK universities in providing 1900 summer school places this year, helped by a three-year grant of £750,000 to the summer school programme from Barclays.

Each year, around 1,500 applicants apply for 664 places at the seven veterinary schools in the UK.

The 50 successful applicants to the RVC summer school this year will enter a week-long residential course with all expenses covered. The academic programme will focus on Bioveterinary Sciences, Veterinary Medicine and Veterinary Nursing taught by full-time academic staff. It will include practical dissections, clinical skills, farm-based sessions and laboratory periods. The participants will also be given sessions on the application process and interviews.

Sir Peter Lampl, chairman of the Sutton Trust and of the Education Endowment Foundation, said: "I'm delighted that the Royal Veterinary College has joined the Sutton Trust UK summer school programme. Veterinary courses are highly competitive, but it is vital that young people from low and middle income backgrounds have a fair chance to access them.

"Veterinary life is an attractive career choice for many bright young people, not just for the interest and variety of the work but also for the earning opportunities. The 50 students who enrol at the Royal Veterinary College this year will be given the best opportunity to prepare for university courses through our highly successful summer school model."
 
Professor Stuart Reid, Principal at the Royal Veterinary College, said:  "For many years the Royal Veterinary College has been focused on widening access to veterinary education to the most able students regardless of their background. The Sutton Trust has a long and successful tradition of supporting under-privileged students into higher education and we are proud to be working with the Trust's summer school programme.

"We hope that the summer school will demonstrate the broad range of exciting opportunities available to students with an interest in veterinary science and encourage more students from non-traditional backgrounds to consider a veterinary career."

Young people interested in applying to Sutton Trust summer schools can find more information at http://www.suttontrust.com/students/uk-summer-schools/

Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.

Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.

As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.

The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.

John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.

"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."

Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.

The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.

The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.

Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.

Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.

"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.

"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."

For further information on Osteokine, contact Genitrix on 01403 786345. 

Bayer Animal Health, the maker of Veraflox, has produced a new animation which explains the considerations veterinary surgeons should take into account when choosing which antibiotic to prescribe. 

The animation outlines the key steps that should be taken when faced with a suspected bacterial infection and includes factors such as culture and sensitivity testing, resistance and the mutant prevention concentration.

The company says it produced the animation in response to research it carried out last year in which nearly 500 veterinary professionals (465 practising vets and 45 students) participated.

48% said they felt that not enough is being done to educate veterinary professionals on the responsible use of antibiotics and how to avoid exacerbating the urgent issue of antimicrobial resistance.

Vicky McAlister, Group Product Manager at Bayer said: "In response to this research Bayer is developing a suite of educational resources to arm vets with practical and applicable tools that help them look beyond the 'tip of the iceberg' of bacterial infections, educating about not just the clinical cure, but bacteriological cure, too." 

The animation is part of a wider awareness programme entitled ‘What Lies Beneath‘ in which Bayer says it aims to better understand the challenges the veterinary industry faces when prescribing antibiotics, so that additional tools can be developed to help vets confidently use antibiotics responsibly. 

The programme will also include a series of webinars led by experts in various fields including veterinary medicine, laboratory diagnostics experts, behavioural psychologists and microbiologists. The webinars are due to be released later in the year, and will present a different perspective on common issues such as compliance, how to make appropriate antimicrobial choices and the approach to and interpretation of relevant diagnostic tests.  

A new study, published in the latest issue of the Journal of Small Animal Practice (JSAP), has found that key surfaces in the small animal veterinary hospital setting are unlikely to be cleaned satisfactorily, potentially posing a risk to both animal and human health.

In the study, Fluorescent tagging for environmental surface cleaning surveillance in a veterinary hospital ¹, researchers at Ohio State University used a fluorescent dye to tag pre-determined surfaces in a large veterinary teaching hospital.

The dye was invisible to the naked eye, but fluoresced under a blacklight (UV-A source). It could be easily removed by regular cleaning.

Surfaces were tagged and then assessed 24 hours after tag placement to determine whether they had been cleaned. Tagging and assessment took place during non-peak hours in an attempt to eliminate observer bias. The study ran for a period of 5.5 weeks between June and July 2014 and a total of 4984 surfaces were tagged and assessed.

Jason Stull, corresponding author of the paper said: "Overall, 50% of surfaces were adequately cleaned so that the tag was completely removed. Cleaning varied widely by surface/object and hospital location. Of the surfaces designated as having primarily human contact, the equipment cart and door handle to the dog walking area were most frequently cleaned (100%), whilst examination equipment including the otoscope, ophthalmoscope and swivel light handle were the least frequently cleaned (2.3%).

"Of the surfaces designated as having primarily animal contact, the ward cage interior was the most frequently cleaned (89.0%) whilst the dog run interior was the least frequently cleaned (23.1%). In terms of hospital location, the most frequently cleaned area was radiology (77.5%) and the least frequently cleaned area was the small animal treatment area (4.2%)."

The overall proportion of surfaces satisfactorily cleaned was similar to that reported in previous studies, however, the findings for some surfaces and hospital areas differed.² This demonstrates the importance of veterinary cleaning surveillance in individual practices so that targeted interventions can be implemented.

Nicholas Jeffery, editor of JSAP said: "With health-care associated infections being a persistent problem in human and veterinary medicine, it is important that surfaces and equipment within the veterinary practice are adequately cleaned. This research demonstrates the potential use of a commercial fluorescent dye for veterinary cleaning surveillance to inform hospital cleaning practices."

The full article can be found in the February issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13090 

References

1. G. Langdon, A. E. Hoet, J. W. Stull (2020) Fluorescent tagging for environmental surface cleaning surveillance in a veterinary hospital. Journal of Small Animal Practice, 61 (2). Available at: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13090
2. J. S. Weese, T. Lowe, M. Walker. (2012) Use of fluorescent tagging for assessment of environmental cleaning and disinfection in a veterinary hospital. Veterinary Record, 171. Available at: https://veterinaryrecord.bmj.com/content/171/9/217.info

Dechra Veterinary Products has announced the appointment of Bob Parmenter as managing director of its UK business. 

Commenting on his appointment, Bob said: "I'm pleased to have joined Dechra at a very exciting stage of the company's development. I've been following the growth of Dechra over recent years and with its acquisition of VetXX in January, I believe that the business is now strongly placed to further establish itself as a leading player in the animal health industry."

Having spent nearly 40 years in the industry, Bob Parmenter has previously worked for Schering-Plough, Mallinckrodt Veterinary, Pitman-Moore, Coopers Animal Health and ICI Pharmaceuticals. "My career path has enabled me to experience all aspects of the animal health market. I'm confident my industry-wide knowledge will provide Dechra with additional experience as we continue to build our reputation and strengthen our UK market position."

Former MD Giles Coley, who joined Dechra in 1999 and has managed the UK business since 2003, has been promoted to European Pharmaceutical and Export Sales Director.  As a member of Dechra Veterinary Product's European Board he will be responsible for co-ordinating pharmaceutical sales across Europe and developing the company's export sales.

The Kennel Club has confirmed that the BBC has pulled out of broadcasting Crufts next year. 

According to the Kennel Club, the decision was reached following what it described as 'unreasonable demands' from the BBC, including the exclusion of certain breeds of dog from the group competition at the show.

The Kennel Club says the BBC's demands took no account of the measures it has in place to improve the health of pedigree dogs, or of the fact that judges will be trained to help ensure that all dogs being awarded prizes at Crufts will be healthy representatives of their breed.

Ronnie Irving, Kennel Club Chairman, said "I am very sorry that BBC audiences around the world will not be able to join us in celebrating all dogs in 2009 and to see the remarkable diversity of dogs and activities on show at Crufts; ranging from the show classes to agility displays, the Friends for Life competition and the unsung heroes who take part in breed rescue.

"However, we have been forced to reject the insupportable conditions imposed by the BBC, who have told us they will only televise the show in 2009 if certain breeds are excluded from participating.We are unable to agree to these demands, as it would compromise both contractual obligations and our general responsibility to dog exhibitors and our audience and we believe it would be inappropriate and counterproductive to exclude any recognised breed from Crufts.

"We are obviously disappointed and confused with this outcome as we hoped the broadcast would have supported our focus on health and welfare issues, given advice about caring for and training dogs and showcased the charitable work that we support. This TV exposure would have benefited all dogs and given viewers a well-rounded picture of what the new Crufts in 2009 is all about."

In October 2008 the Kennel Club announced a strategy to show how it is focusing its activities on the health and welfare of all dogs. It announced mandatory compliance with a strict code of ethics for all breed clubs registered with the Kennel Club.

Earlier this month, it completed a review for each of the 209 pedigree dog breeds in the UK and announced revised standards that it says will have far-reaching benefits for the health and welfare of dogs. These new breed standards and health plans will benefit from research that has been funded by the Kennel Club in conjunction with veterinary research centres over a number of years. The overall aim is that all pedigree dogs should be fit for function and that breeders and judges should not reward dogs with obvious conditions or exaggerations, which would be detrimental in any way to their health.